Literature DB >> 20532992

Methamphetamine-induced behavioral and physiological effects in adolescent and adult HIV-1 transgenic rats.

Marley D Kass1, Xiangqian Liu, Michael Vigorito, Linda Chang, Sulie L Chang.   

Abstract

We recently reported that six consecutive days of treatment with a moderate dose of methamphetamine (METH) induced greater behavioral sensitization in adult HIV-1 transgenic (HIV-1 Tg) rats than in adult Fischer 344/NHsd (F344) non-transgenic, wild-type control animals. In the present study, we evaluated the effects of a moderate dose of METH on the brains of adolescent versus adult HIV-1 Tg male rats using both behavioral (METH-induced, stereotypic head movement) and physiological (rectal body temperature) parameters. We found that both the acute and behavior-sensitizing effects of METH were greater in HIV-1 Tg rats compared with controls and also in adolescent rats compared with adult animals, regardless of HIV-1 status. We determined that acute hyperthermic effects of METH as well as tolerance to METH-induced hyperthermia were greater in HIV-1 Tg rats than in controls. Taken together, these results suggest that both the neuroadaptations seen in HIV infection and the immaturity of the adolescent brain are associated with increased sensitivity to the psychoactive and behavior-sensitizing properties of METH. Thus, HIV-infected individuals and adolescents may be more vulnerable to the development of METH abuse and dependence than non-infected individuals and adults.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20532992      PMCID: PMC4899043          DOI: 10.1007/s11481-010-9221-z

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  38 in total

Review 1.  Incentive-sensitization and addiction.

Authors:  T E Robinson; K C Berridge
Journal:  Addiction       Date:  2001-01       Impact factor: 6.526

2.  Tolerance to the neurotoxic effects of methamphetamine in young rats.

Authors:  Evan L Riddle; Jerry M Kokoshka; Diana G Wilkins; Glen R Hanson; Annette E Fleckenstein
Journal:  Eur J Pharmacol       Date:  2002-01-25       Impact factor: 4.432

Review 3.  Affective neuroscience of pleasure: reward in humans and animals.

Authors:  Kent C Berridge; Morten L Kringelbach
Journal:  Psychopharmacology (Berl)       Date:  2008-03-03       Impact factor: 4.530

Review 4.  Review. The incentive sensitization theory of addiction: some current issues.

Authors:  Terry E Robinson; Kent C Berridge
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-10-12       Impact factor: 6.237

5.  An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction.

Authors:  W Reid; M Sadowska; F Denaro; S Rao; J Foulke; N Hayes; O Jones; D Doodnauth; H Davis; A Sill; P O'Driscoll; D Huso; T Fouts; G Lewis; M Hill; R Kamin-Lewis; C Wei; P Ray; R C Gallo; M Reitz; J Bryant
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-31       Impact factor: 11.205

Review 6.  Addiction, compulsive drug seeking, and the role of frontostriatal mechanisms in regulating inhibitory control.

Authors:  Jodie Feil; Dianne Sheppard; Paul B Fitzgerald; Murat Yücel; Dan I Lubman; John L Bradshaw
Journal:  Neurosci Biobehav Rev       Date:  2010-03-17       Impact factor: 8.989

7.  A sensitizing regimen of methamphetamine causes impairments in a novelty preference task of object recognition.

Authors:  Annabelle M Belcher; Steven J O'Dell; John F Marshall
Journal:  Behav Brain Res       Date:  2006-04-04       Impact factor: 3.332

8.  Physiological and behavioral effects of methamphetamine in a mouse model of endotoxemia: a preliminary study.

Authors:  Manuel Sánchez-Alavez; Lhys M Gombart; Salvador Huitrón-Reséndiz; Janai R Carr; Derek N Wills; Greta Berg; Iain L Campbell; David V Gauvin; Steven J Henriksen; José R Criado
Journal:  Pharmacol Biochem Behav       Date:  2004-02       Impact factor: 3.533

9.  The HIV-1 transgenic rat as a model for HIV-1 infected individuals on HAART.

Authors:  Jinsong Peng; Michael Vigorito; Xiangqian Liu; Dunjing Zhou; Xiongwen Wu; Sulie L Chang
Journal:  J Neuroimmunol       Date:  2009-11-13       Impact factor: 3.478

Review 10.  Neurobiology of HIV, psychiatric and substance abuse comorbidity research: workshop report.

Authors:  Kathy L Kopnisky; Jing Bao; Yu Woody Lin
Journal:  Brain Behav Immun       Date:  2007-03-07       Impact factor: 7.217

View more
  20 in total

Review 1.  Rodent models for HIV-associated neurocognitive disorders.

Authors:  Santhi Gorantla; Larisa Poluektova; Howard E Gendelman
Journal:  Trends Neurosci       Date:  2012-02-01       Impact factor: 13.837

Review 2.  Modulatory Effects of Nicotine on neuroHIV/neuroAIDS.

Authors:  Haijun Han; Zhongli Yang; Sulie L Chang; Ming D Li
Journal:  J Neuroimmune Pharmacol       Date:  2018-09-13       Impact factor: 4.147

3.  Male HIV-1 transgenic rats show reduced cocaine-maintained lever-pressing compared to F344 wildtype rats despite similar baseline locomotion.

Authors:  Y Wendy Huynh; Brady M Thompson; Christopher E Larsen; Shilpa Buch; Ming-Lei Guo; Rick A Bevins; Jennifer E Murray
Journal:  J Exp Anal Behav       Date:  2020-02-20       Impact factor: 2.468

4.  Regional variations of antioxidant capacity and oxidative stress responses in HIV-1 transgenic rats with and without methamphetamine administration.

Authors:  Xiaosha Pang; Jun Panee; Xiangqian Liu; Marla J Berry; Sulie L Chang; Linda Chang
Journal:  J Neuroimmune Pharmacol       Date:  2013-04-02       Impact factor: 4.147

5.  Latest trends in drugs of abuse - HIV infection and neuroAIDS.

Authors:  Sneham Tiwari; Madhavan Pn Nair; Shailendra K Saxena
Journal:  Future Virol       Date:  2013-02       Impact factor: 1.831

6.  Increased Sensitivity to Cocaine Self-Administration in HIV-1 Transgenic Rats is Associated with Changes in Striatal Dopamine Transporter Binding.

Authors:  Scot McIntosh; Tammy Sexton; Lindsey P Pattison; Steven R Childers; Scott E Hemby
Journal:  J Neuroimmune Pharmacol       Date:  2015-03-10       Impact factor: 4.147

7.  Methamphetamine augment HIV-1 Tat mediated memory deficits by altering the expression of synaptic proteins and neurotrophic factors.

Authors:  Anantha Ram Nookala; Daniel C Schwartz; Nitish S Chaudhari; Alexy Glazyrin; Edward B Stephens; Nancy E J Berman; Anil Kumar
Journal:  Brain Behav Immun       Date:  2018-05-02       Impact factor: 7.217

8.  Expression of HIV gp120 protein increases sensitivity to the rewarding properties of methamphetamine in mice.

Authors:  James P Kesby; David T Hubbard; Athina Markou; Svetlana Semenova
Journal:  Addict Biol       Date:  2012-12-18       Impact factor: 4.280

9.  Acquisition and long-term retention of spatial learning in the human immunodeficiency virus-1 transgenic rat: effects of repeated nicotine treatment.

Authors:  Michael Vigorito; Junran Cao; Ming D Li; Sulie L Chang
Journal:  J Neurovirol       Date:  2013-03-02       Impact factor: 2.643

10.  Behavioral effects of chronic methamphetamine treatment in HIV-1 gp120 transgenic mice.

Authors:  Brook L Henry; Mark A Geyer; Mahalah Buell; William Perry; Jared W Young; Arpi Minassian
Journal:  Behav Brain Res       Date:  2012-08-31       Impact factor: 3.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.